|
|
 Previous Article | Table of Contents | Next Article 
Hydroxyurea Can Be Used to Increase Mouse c-kit+Thy-1.1loLin-/loSca-1+ Hematopoietic Cell Number and Frequency in Cell Cycle In Vivo
Nobuko Uchida,
Annabelle M. Friera,
Dongping He,
Michael J. Reitsma,
Ann S. Tsukamoto, and
Irving L. Weissman
From SyStemix Inc, Palo Alto; and the Department of Pathology, Stanford School of Medicine, Stanford, CA.
The DNA synthesis inhibitor hydroxyurea (HU) was administered to determine whether it induces changes in the cell-cycle status of primitive hematopoietic stem cells (HSCs)/progenitors. Administration of HU to mice leads to bone marrow accumulation of c-kit+Thy-1.1loLin-/loSca-1+ (KTLS) cells in S/G2/M phases of the cell cycle. HU is a relatively nontoxic, reversible cell-cycle agent that can lead to approximately a threefold expansion of KTLS cells in vivo and approximately an eightfold increase in the number of KTLS cells in S/G2/M. HSCs in HU-treated mice have undiminished multilineage long-term and short-term clonal reconstitution activity.
Blood, Vol. 90 No. 11 (December 1), 1997:
pp. 4354-4362
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E. Passegue, A. J. Wagers, S. Giuriato, W. C. Anderson, and I. L. Weissman
Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates
J. Exp. Med.,
December 5, 2005;
202(11):
1599 - 1611.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Wilson, M. J. Murphy, T. Oskarsson, K. Kaloulis, M. D. Bettess, G. M. Oser, A.-C. Pasche, C. Knabenhans, H. R. MacDonald, and A. Trumpp
c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation
Genes & Dev.,
November 15, 2004;
18(22):
2747 - 2763.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Wang, S. Ge, G. McNamara, Q.-L. Hao, G. M. Crooks, and J. A. Nolta
Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells
Blood,
May 15, 2003;
101(10):
4201 - 4208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wilpshaar, M. Bhatia, H. H. H. Kanhai, R. Breese, D. K. Heilman, C. S. Johnson, J. H. F. Falkenburg, and E. F. Srour
Engraftment potential of human fetal hematopoietic cells in NOD/SCID mice is not restricted to mitotically quiescent cells
Blood,
June 17, 2002;
100(1):
120 - 127.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Orschell-Traycoff, K. Hiatt, R. N. Dagher, S. Rice, M. C. Yoder, and E. F. Srour
Homing and engraftment potential of Sca-1+lin- cells fractionated on the basis of adhesion molecule expression and position in cell cycle
Blood,
August 15, 2000;
96(4):
1380 - 1387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. W. Austin, S. Salimi, G. Veres, F. Morel, H. Ilves, R. Scollay, and I. Plavec
Long-term multilineage expression in peripheral blood from a Moloney murine leukemia virus vector after serial transplantation of transduced bone marrow cells
Blood,
February 1, 2000;
95(3):
829 - 836.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. H. Cheshier, S. J. Morrison, X. Liao, and I. L. Weissman
In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells
PNAS,
March 16, 1999;
96(6):
3120 - 3125.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
